Cargando…
Transgenic inhibition of interleukin-6 trans-signaling does not prevent skeletal pathologies in mucolipidosis type II mice
Severe skeletal alterations are common symptoms in patients with mucolipidosis type II (MLII), a rare lysosomal storage disorder of childhood. We have previously reported that progressive bone loss in a mouse model for MLII is caused by an increased number of bone-resorbing osteoclasts, which is acc...
Autores principales: | Westermann, Lena Marie, Baranowsky, Anke, Di Lorenzo, Giorgia, Danyukova, Tatyana, Soul, Jamie, Schwartz, Jean-Marc, Hendrickx, Gretl, Amling, Michael, Rose-John, Stefan, Garbers, Christoph, Schinke, Thorsten, Pohl, Sandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878873/ https://www.ncbi.nlm.nih.gov/pubmed/33574442 http://dx.doi.org/10.1038/s41598-021-82802-3 |
Ejemplares similares
-
Imbalanced cellular metabolism compromises cartilage homeostasis and joint function in a mouse model of mucolipidosis type III gamma
por: Westermann, Lena Marie, et al.
Publicado: (2020) -
Enzyme replacement therapy in mice lacking arylsulfatase B targets bone-remodeling cells, but not chondrocytes
por: Hendrickx, Gretl, et al.
Publicado: (2020) -
Pathogenic variants in GNPTAB and GNPTG encoding distinct subunits of GlcNAc-1-phosphotransferase differentially impact bone resorption in patients with mucolipidosis type II and III
por: Di Lorenzo, Giorgia, et al.
Publicado: (2021) -
Role of c-Fos in orthodontic tooth movement: an in vivo study using transgenic mice
por: Decker, Maximilian G., et al.
Publicado: (2020) -
Decreased bone formation and increased osteoclastogenesis cause bone loss in mucolipidosis II
por: Kollmann, Katrin, et al.
Publicado: (2013)